Risperidone solid dispersion for orally disintegrating tablet: its formulation design and non-destructive methods of evaluation.
about
Nanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteers.Novel levocetirizine HCl tablets with enhanced palatability: synergistic effect of combining taste modifiers and effervescence techniqueImprovement of Meloxicam Solubility Using a β-Cyclodextrin Complex Prepared via the Kneading Method and Incorporated into an Orally Disintegrating TabletDevelopment and optimization of a meloxicam/β-cyclodextrin complex for orally disintegrating tablet using statistical analysis.Challenges and emerging solutions in the development of compressed orally disintegrating tablets.Physico-mechanical and stability evaluation of carbamazepine cocrystal with nicotinamideDevelopment and physicochemical characterization of sirolimus solid dispersions prepared by solvent evaporation method.Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration.Novel taste-masked orally disintegrating tablets for a highly soluble drug with an extremely bitter taste: design rationale and evaluation.Comparison of nanomilling and coprecipitation on the enhancement of in vitro dissolution rate of poorly water-soluble model drug aripiprazole.Solid formulation of a supersaturable self-microemulsifying drug delivery system for valsartan with improved dissolution and bioavailability.The Impact of Amorphisation and Spheronization Techniques on the Improved in Vitro & in Vivo Performance of Glimepiride Tablets.Effervescent tablet formulation for enhanced patient compliance and the therapeutic effect of risperidone.
P2860
Q33800631-FC5651A8-6A98-42A6-8DF1-C226402B37A7Q36052357-FB38CD7A-D45B-4658-A2D0-514062C0510BQ36170099-6AFE387D-5ACC-4A94-9A4F-15DAFBB94381Q36201299-24A93208-1CA3-40B4-9F5A-A8E9599745F2Q38232117-B7C46E98-FCAF-443C-94D2-2CE7C8900D92Q41988576-81E8D0E8-7109-4184-A853-54EB724948D1Q42012873-9B957466-75F6-4B12-BFD0-B184944EC58DQ43216548-4D4AD1C6-9180-484D-9432-A965B0367906Q43957526-CFA48120-6204-482C-A74C-95D917F58F99Q44639623-CD55B266-BED3-440C-AFC0-A29BB023036AQ47095543-DA873553-0067-40FF-ACC8-E48EEAA91DB0Q49265974-F0547495-ACBC-46DA-9B6C-EE1B1D104527Q53843332-F900D664-47D7-4DC7-BB16-068CCD28CE5D
P2860
Risperidone solid dispersion for orally disintegrating tablet: its formulation design and non-destructive methods of evaluation.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Risperidone solid dispersion f ...... ructive methods of evaluation.
@en
Risperidone solid dispersion f ...... ructive methods of evaluation.
@nl
type
label
Risperidone solid dispersion f ...... ructive methods of evaluation.
@en
Risperidone solid dispersion f ...... ructive methods of evaluation.
@nl
prefLabel
Risperidone solid dispersion f ...... ructive methods of evaluation.
@en
Risperidone solid dispersion f ...... ructive methods of evaluation.
@nl
P1476
Risperidone solid dispersion f ...... ructive methods of evaluation.
@en
P2093
Ahmed S Zidan
Mansoor A Khan
P356
10.1016/J.IJPHARM.2010.08.025
P407
P577
2010-08-27T00:00:00Z